IL110366A - 1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them - Google Patents

1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL110366A
IL110366A IL11036694A IL11036694A IL110366A IL 110366 A IL110366 A IL 110366A IL 11036694 A IL11036694 A IL 11036694A IL 11036694 A IL11036694 A IL 11036694A IL 110366 A IL110366 A IL 110366A
Authority
IL
Israel
Prior art keywords
dioxo
benzodiazepin
compounds
group
tetrahydro
Prior art date
Application number
IL11036694A
Other languages
English (en)
Other versions
IL110366A0 (en
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of IL110366A0 publication Critical patent/IL110366A0/xx
Publication of IL110366A publication Critical patent/IL110366A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL11036694A 1993-07-20 1994-07-19 1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them IL110366A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314981A GB9314981D0 (en) 1993-07-20 1993-07-20 Chemical compounds

Publications (2)

Publication Number Publication Date
IL110366A0 IL110366A0 (en) 1994-10-21
IL110366A true IL110366A (en) 1999-01-26

Family

ID=10739096

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11036694A IL110366A (en) 1993-07-20 1994-07-19 1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them

Country Status (32)

Country Link
US (1) US5716953A (pl)
EP (1) EP0710230B1 (pl)
JP (1) JP3587849B2 (pl)
KR (1) KR100347287B1 (pl)
CN (1) CN1050835C (pl)
AP (1) AP492A (pl)
AT (1) ATE171167T1 (pl)
AU (1) AU687858B2 (pl)
CA (1) CA2167308A1 (pl)
CO (1) CO4290299A1 (pl)
CZ (1) CZ290472B6 (pl)
DE (1) DE69413405T2 (pl)
DK (1) DK0710230T3 (pl)
EC (1) ECSP941120A (pl)
ES (1) ES2123812T3 (pl)
FI (1) FI960223A7 (pl)
GB (1) GB9314981D0 (pl)
HR (1) HRP940411B1 (pl)
HU (1) HU222439B1 (pl)
IL (1) IL110366A (pl)
IS (1) IS4190A (pl)
MY (1) MY118638A (pl)
NO (1) NO313288B1 (pl)
NZ (1) NZ271075A (pl)
PE (1) PE8295A1 (pl)
PL (1) PL175609B1 (pl)
RU (1) RU2135485C1 (pl)
SI (1) SI0710230T1 (pl)
SV (1) SV1994000031A (pl)
TW (1) TW290542B (pl)
WO (1) WO1995003285A1 (pl)
ZA (1) ZA945238B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739129A (en) * 1994-04-14 1998-04-14 Glaxo Wellcome Inc. CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
WO1998002419A1 (en) * 1996-07-12 1998-01-22 Chugai Seiyaku Kabushiki Kaisha Cancer cell proliferation inhibitors
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US6569851B1 (en) * 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6958330B1 (en) 1998-06-22 2005-10-25 Elan Pharmaceuticals, Inc. Polycyclic α-amino-ε-caprolactams and related compounds
AU779874B2 (en) 1999-10-15 2005-02-17 F. Hoffmann-La Roche Ag Benzodiazepine derivatives
US20050192265A1 (en) * 2003-03-20 2005-09-01 Thompson Richard C. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
SI1673347T1 (sl) * 2003-10-06 2015-10-30 F. Hoffmann - La Roche Ag Substituirani derivati dibenzo-azepina in benzo-diazepina, ki so uporabni kot inhibitorji gama-sekretaze
WO2005084595A1 (en) * 2004-02-27 2005-09-15 Cardiacmd, Inc. Prosthetic heart valve delivery systems and methods
MX2009010729A (es) * 2007-04-19 2009-10-26 Hoffmann La Roche Derivados de dihidro-benzo[b] [1,4]diazepin-2-ona-sulfonamida.
RU2540464C2 (ru) * 2012-05-28 2015-02-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Водорастворимое производное амида салициловой кислоты, обладающее транквилизирующей, ноотропной и анальгезирующей активностью
CN103435562B (zh) * 2013-08-26 2016-02-24 华东理工大学 6-取代苯并二氮卓-2,4-二酮类化合物及其用途
RU2702359C1 (ru) * 2019-06-04 2019-10-08 Федеральное государственное бюджетное научное учреждение Уфимский федеральный исследовательский центр Российской академии наук Способ получения 2,2,4-триалкил-2,3-дигидро-1Н-1,5-бензодиазепинов

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103745A1 (de) * 1971-01-27 1972-08-10 CH. Boehringer Sohn, 6507 Ingelheim Neue 5-AryJ-(bzw. Heteroaryl)-3-hydroxylH-l,5-benzodiazepin-2,4-(3H,5H)-dioneund Verfahren zu ihrer Herstellung
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
GB9201181D0 (en) * 1992-01-21 1992-03-11 Glaxo Spa Chemical compounds
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives

Also Published As

Publication number Publication date
IL110366A0 (en) 1994-10-21
JP3587849B2 (ja) 2004-11-10
PL312659A1 (en) 1996-04-29
ECSP941120A (es) 1995-01-16
CO4290299A1 (es) 1996-04-17
DE69413405T2 (de) 1999-04-15
CZ17396A3 (en) 1996-07-17
AP492A (en) 1996-05-13
AU687858B2 (en) 1998-03-05
HU9600124D0 (en) 1996-03-28
CN1050835C (zh) 2000-03-29
DK0710230T3 (da) 1999-06-14
HU222439B1 (hu) 2003-07-28
US5716953A (en) 1998-02-10
NZ271075A (en) 1998-06-26
ATE171167T1 (de) 1998-10-15
JPH09502428A (ja) 1997-03-11
DE69413405D1 (de) 1998-10-22
HRP940411B1 (en) 2000-12-31
FI960223A7 (fi) 1996-03-19
CA2167308A1 (en) 1995-02-02
SI0710230T1 (en) 1999-02-28
IS4190A (is) 1995-01-21
CN1138853A (zh) 1996-12-25
SV1994000031A (es) 1995-10-04
TW290542B (pl) 1996-11-11
RU2135485C1 (ru) 1999-08-27
NO313288B1 (no) 2002-09-09
PE8295A1 (es) 1995-04-20
GB9314981D0 (en) 1993-09-01
ZA945238B (en) 1995-02-09
EP0710230A1 (en) 1996-05-08
MY118638A (en) 2004-12-31
HRP940411A2 (en) 1997-04-30
CZ290472B6 (cs) 2002-07-17
PL175609B1 (pl) 1999-01-29
AU7458994A (en) 1995-02-20
HUT73499A (en) 1996-08-28
NO960237L (no) 1996-03-19
WO1995003285A1 (en) 1995-02-02
FI960223A0 (fi) 1996-01-17
ES2123812T3 (es) 1999-01-16
KR100347287B1 (ko) 2002-12-06
NO960237D0 (no) 1996-01-19
EP0710230B1 (en) 1998-09-16
AP9400657A0 (en) 1994-07-31

Similar Documents

Publication Publication Date Title
RU2124009C1 (ru) Производные 1,5-бензодиазепина, способ их получения, фармацевтическая композиция
AP462A (en) 1,5 Benzodiazepine derivatives.
EP0710230B1 (en) 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
EP0538945A1 (en) Benzodiazepine derivatives, and their use as antagonists of gastrin and/or cholecystokinin
US5686449A (en) 1,5-benzodiazepines useful as gastrinor CCK-antagonists
AU688316B2 (en) 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
EP0698014B1 (en) 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or cck antagonists
US5486514A (en) Carbamate derivatives
EP0710229B1 (en) 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
WO1995003299A1 (en) 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees